Search research articles
Contact Us
Filters
Showing results (191-200 of 346) with videos related to
Page
of 35
Sort By:
Leukemia & Lymphoma
|
October 31, 2025
Cladribine, high-dose cytarabine, plus gemtuzumab ozogamicin (CLAG-GO) as frontline intensive therapy for fit patients with core-binding factor acute myeloid leukemia
Roberta S Azevedo, Julie Braish, Georgina Gener-Ricos, et al.
Leukemia & Lymphoma
|
March 31, 2025
Mutation dynamics from diagnosis to relapse in acute myeloid leukemia with chromosomal 7 deletions
Eitan Kugler, Enes Dasdemir, Alex Bataller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 19, 2024
Results of the Simultaneous Combination of Ponatinib and Blinatumomab in Philadelphia Chromosome-Positive ALL
Hagop Kantarjian, Nicholas J Short, Fadi G Haddad, et al.
Leukemia & Lymphoma
|
September 3, 2021
Prognostic impact of conventional cytogenetics in acute myeloid leukemia treated with venetoclax and decitabine
Sangeetha Venugopal, Abhishek Maiti, Courtney D DiNardo, et al.
Acta Haematologica
|
April 15, 2020
Venetoclax and BCR-ABL Tyrosine Kinase Inhibitor Combinations: Outcome in Patients with Philadelphia Chromosome-Positive Advanced Myeloid Leukemias
Abhishek Maiti, Miguel J Franquiz, Farhad Ravandi, et al.
American Journal of Hematology
|
May 15, 2023
Ultrasensitive NGS MRD assessment in Ph+ ALL: Prognostic impact and correlation with RT-PCR for BCR::ABL1
Nicholas J Short, Elias Jabbour, Walid Macaron, et al.
Blood Advances
|
December 22, 2020
Prognostic impact of complete remission with MRD negativity in patients with relapsed or refractory AML
Nicholas J Short, Hind Rafei, Naval Daver, et al.
Blood
|
August 25, 2017
Clonal chromosomal abnormalities appearing in Philadelphia chromosome-negative metaphases during CML treatment
Ghayas C Issa, Hagop M Kantarjian, Graciela Nogueras Gonzalez, et al.
Cancer
|
April 9, 2024
Combination of dasatinib and venetoclax in newly diagnosed chronic phase chronic myeloid leukemia
Elias Jabbour, Fadi G Haddad, Koji Sasaki, et al.
American Journal of Hematology
|
March 16, 2017
Outcomes of adults with relapsed or refractory Burkitt and high-grade B-cell leukemia/lymphoma
Nicholas J Short, Hagop M Kantarjian, Heidi Ko, et al.
Page
of 35
Search research articles
Search
Showing results (191-200 of 346) with videos related to
Sort By:
Page
of 35
Leukemia & Lymphoma
|
October 31, 2025
Cladribine, high-dose cytarabine, plus gemtuzumab ozogamicin (CLAG-GO) as frontline intensive therapy for fit patients with core-binding factor acute myeloid leukemia
Roberta S Azevedo, Julie Braish, Georgina Gener-Ricos, et al.
Leukemia & Lymphoma
|
March 31, 2025
Mutation dynamics from diagnosis to relapse in acute myeloid leukemia with chromosomal 7 deletions
Eitan Kugler, Enes Dasdemir, Alex Bataller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 19, 2024
Results of the Simultaneous Combination of Ponatinib and Blinatumomab in Philadelphia Chromosome-Positive ALL
Hagop Kantarjian, Nicholas J Short, Fadi G Haddad, et al.
Leukemia & Lymphoma
|
September 3, 2021
Prognostic impact of conventional cytogenetics in acute myeloid leukemia treated with venetoclax and decitabine
Sangeetha Venugopal, Abhishek Maiti, Courtney D DiNardo, et al.
Acta Haematologica
|
April 15, 2020
Venetoclax and BCR-ABL Tyrosine Kinase Inhibitor Combinations: Outcome in Patients with Philadelphia Chromosome-Positive Advanced Myeloid Leukemias
Abhishek Maiti, Miguel J Franquiz, Farhad Ravandi, et al.
American Journal of Hematology
|
May 15, 2023
Ultrasensitive NGS MRD assessment in Ph+ ALL: Prognostic impact and correlation with RT-PCR for BCR::ABL1
Nicholas J Short, Elias Jabbour, Walid Macaron, et al.
Blood Advances
|
December 22, 2020
Prognostic impact of complete remission with MRD negativity in patients with relapsed or refractory AML
Nicholas J Short, Hind Rafei, Naval Daver, et al.
Blood
|
August 25, 2017
Clonal chromosomal abnormalities appearing in Philadelphia chromosome-negative metaphases during CML treatment
Ghayas C Issa, Hagop M Kantarjian, Graciela Nogueras Gonzalez, et al.
Cancer
|
April 9, 2024
Combination of dasatinib and venetoclax in newly diagnosed chronic phase chronic myeloid leukemia
Elias Jabbour, Fadi G Haddad, Koji Sasaki, et al.
American Journal of Hematology
|
March 16, 2017
Outcomes of adults with relapsed or refractory Burkitt and high-grade B-cell leukemia/lymphoma
Nicholas J Short, Hagop M Kantarjian, Heidi Ko, et al.
Page
of 35